{"id":56757,"name":"REZOLUTE","slug":"rezolute","state":"CA","country":"United States of America","description":"clinical stage biopharmaceutical company creating therapies for metabolic diseases","totalSpending":330000,"filings":12,"yearlySpending":[{"year":2023,"income":40000},{"year":2024,"income":200000},{"year":2025,"income":90000}],"issues":["HCR","PHA"],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["KATHERINE LANDES","ALEXANDER ROOT","JACOB JACKSON","PATROSKI LAWSON","PAULA GUTIERREZ"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FDA issues and health care reform","H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]","S.1906 - Promising Pathway Act","S.1906 - Promising Pathway Act","FDA Issues and health care reform"],"years":[2023,2024,2025]}